SomaLogic opens their first-ever proteomics grant program to APAC life sciences researchers

Two winners will be awarded 40 human plasma or serum samples to be processed on the SomaScan® Platform at Genomax’s Singapore lab

SINGAPORE & BOULDER, Colo., May 07, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a global leader in proteomics technology, today announced that it is sponsoring the Genomax Research Grant Award for researchers in Singapore. This effort is SomaLogic’s first grant in the APAC region. The winners of the award will receive proteomic data from SomaLogic’s 7,000-plex assay, which will be run at Singapore-based Molecular Genomics, a Genomax Technologies company. The Genomax site, opened in November 2022, was the first SomaLogic authorized site in Asia to offer the SomaScan® Platform.

The grant program, which was launched at the Asia Oceana Human Proteome Organisation (AOHUPO) meeting in Singapore, requires that researchers in academic, medical centers, pharmaceutical companies, and contract research organizations in life sciences, submit a proposal outlining how they will use the SomaScan Platform to expand their research goals in health or in a specific disease area. Two winners will be awarded 40 human plasma or serum samples to be processed on the SomaScan Platform at Genomax’s Singapore lab. Researchers can apply on SomaLogic’s website: http://somalogic.com/genomaxgrant2023.

While experts across the region have long embraced the value of genomics, life science researchers in Asia are now increasingly appreciating the power and the promise of proteomics in their discovery efforts. SomaLogic’s proprietary protein detection and analysis technology measures how proteins function and interact, supporting researchers in drug research and development, and biomarker identification efforts.

“Asia is an incredibly important and rapidly growing market because of their increasing focus on translational work in life sciences and clinical research,” said SomaLogic Chief Executive Officer Adam Taich. “We are excited to bring this inaugural grant program to researchers in Singapore who can advance their studies through our partnership with Molecular Genomics, which has been accelerating biodiscovery in Southeast Asia for more than a decade.”

About SomaLogic 
SomaLogic is catalyzing drug research and development and biomarker identification as a global leader in proteomics technology. With a single 55 microliter plasma or serum sample, SomaLogic can run 7,000 protein measurements, covering more than a third of the approximately 20,000 proteins in the human body and twice as many as other proteomic platforms. For more than 20 years we’ve supported pharmaceutical companies, and academic and contract research organizations who rely on our protein detection and analysis technologies to fuel drug, disease, and treatment discoveries in such areas as oncology, diabetes, and cardiovascular, liver and metabolic diseases. Find out more at www.somalogic.com and follow @somalogic on LinkedIn.

Forward Looking Statements Disclaimer 
This press release contains certain forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. All statements, other than statements of historical fact included in this press release, regarding our strategy, future operations, financial position, estimated revenues, projections, prospects, plans and objectives of management are forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “forecast,” “guidance,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “continue,” “will likely result,” “possible,” “potential,” “predict,” “pursue,” “target” and similar expressions, although not all forward-looking statements contain such identifying words. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward-looking statements do not guarantee future performance and involve known and unknown risks, uncertainties and other factors. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including factors which are beyond SomaLogic’s control. You should carefully consider these risks and uncertainties, including, but not limited to, those factors described under Part I, Item 1A – “Risk Factors” in our Annual Report on Form 10-K and other filings we make with the Securities and Exchange Commission. These filings identify and address important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and SomaLogic assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The Company will not and does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. 

Media Contact
Emilia Costales
720-798-5054
ecostales@somalogic.com

Investor Contacts
Lauren Glaser 
Lglaser@somalogic.com 


SomaLogic opens their first-ever proteomics grant program to APAC life sciences researchers

THỦ THUẬT HAY

10 ứng dụng dành cho Android đang miễn phí và giảm giá

Tiếp tục cập nhật danh sách 'Free App' hằng ngày dành cho smartphone Android, TCN đã tổng hợp thêm khá nhiều ứng dụng và game trả phí đang được miễn phí. Nếu bạn quan tâm hãy nhanh tay tải về trước khi bị tính phí trở

Cách khai báo y tế nhanh trên PC Covid cực đơn giản chỉ với một chạm

Cách khai báo y tế nhanh trên PC Covid cực kỳ đơn giản và nhanh chóng giúp bạn khai báo y tế cho bản thân mình chỉ với ‘một chạm’ khi sức khoẻ bình thường.

9 gói giao diện miễn phí đến từ Microsoft, mời các bạn tải về

Microsoft vừa phát hành 09 giao diện (theme) mới hoàn toàn miễn phí cho Windows 10 trên Microsoft Store. Nếu muốn thay giao diện và hình nền Windows 10 mới, hãy lựa chọn và tải về nhé.

Giải quyết tình trạng điện thoại chạy chậm dần theo thời gian

Nếu cảm thấy chiếc điện thoại của bạn bỗng dưng chạy chậm đi trông thấy, bạn hãy kiểm tra xem liệu mình đã thực hiện những thao tác sau chưa.

Google Maps cung cấp tính năng tìm nơi đậu xe

Mới đây, Google Maps đã giới thiệu công cụ giúp người dùng tìm chỗ đỗ xe. Bất cứ ai đi trong hoặc vào thành phố đều biết rằng tìm được chỗ đậu xe là một vấn đề khá nan giải. Hơn nữa, nếu bạn đang lái xe vào một nơi mà

ĐÁNH GIÁ NHANH

Cảm nhận thiết kế OPPO F9: dành cho những người yêu cái đẹp

OPPO F9 đã có một bước tiến lớn so với các thế hệ trước và so với các đối thủ nhờ thiết kế màn hình “giọt nước” độc đáo. Đây cũng là chiếc điện thoại OPPO dòng F đầu tiên có camera kép để cạnh tranh sòng phẳng với những

Porsche Cayenne 2019 - Tiếp tục là chiếc Porsche của thế giới SUV

Porsche cần tới 53 năm để bán 1 triệu chiếc 911 nhưng chỉ cần 15 năm để tìm được 700.000 chủ nhân Cayenne và họ dự kiến chỉ cần thêm 3 năm nữa để đạt cột mốc 1 triệu xe. Những con số trên cho thấy tầm quan trọng của

So sánh Xiaomi Redmi Note 11, Redmi Note 11 Pro và Redmi Note 11 Pro+

Nếu bạn đang phân vân bản thân nên mua Redmi Note 11, Redmi Note 11 Pro hay bản cao cấp nhất Redmi Note 11 Pro+ thì câu trả lời đang có ở trong bài phân tích này